Gastrointestinal and hepatic infections are very common including (Helicobacter pylori gastritis, infectious diarrhea, bacterial peritonitis, bacterial hepatitis and pancreatitis). The increased rise of antimicrobial resistacne of bacteria to anitbiotics is now the leading cause of death worldwide according to a recent published meta-analysis in the Lancet journal. The impact of resistant bacterial infections in the gastrointestinal system is high, increasing mortality and morbidity in even the simplest infectious diseases. In addition, there is increased use of antibiotics in the current COVID-19 pandemic, that may cause more problems in the future antimicrobial resistance. This is a literature review of the current situation and furture insight on the solutions presented by the scientific and the clincial world.
What will audience learn from your presentation?
- In this presentation will aim to address the issue of antimicrobial resistance through showing the epidemiological weight of the probelem, and its impact on the current clinical guidleines of treating GIT infections.
- The presentation will also aim to present the problems of different study designs in addressing the clinical problem of AMR in the gastrointestinal tract.
- The presentation will discuss the limitations encountered in the current clinical practice in addressing the AMR? This is a systemic review of the current literature.
The presentation will display the future prospects of the new antimicrobials currently in clinical trials